PM
Paul A Mahon
EVP & General Counsel

Paul A Mahon insider trades: UNITED THERAPEUTICS (UTHR) stock sales

EVP & General Counsel, UNITED THERAPEUTICS Last trade Nov 5, 2026 447 Form 4 filings
$103.8M
Sold, last 12 months
23 sales
$0
Bought, last 12 months
0 buys
307
Open-market trades
since 2005
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Paul reports to the SEC

Open-market buys and sales

307 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 5, 2026UTHR↓ Sell$5.0M
Oct 15, 2026UTHR↓ Sell$4.5M
Oct 1, 2026UTHR↓ Sell$4.7M
Sep 17, 2026UTHR↓ Sell$4.1M
Sep 3, 2026UTHR↓ Sell$4.0M
Aug 20, 2026UTHR↓ Sell$4.3M
Jul 16, 2026UTHR↓ Sell$4.4M
Jul 2, 2026UTHR↓ Sell$4.6M
Jun 18, 2026UTHR↓ Sell$4.5M
Jun 4, 2026UTHR↓ Sell$4.5M
May 21, 2026UTHR↓ Sell$4.7M
May 7, 2026UTHR↓ Sell$4.9M
Apr 16, 2026UTHR↓ Sell$4.8M
Apr 2, 2026UTHR↓ Sell$4.7M
Mar 19, 2026UTHR↓ Sell$4.4M
Mar 5, 2026UTHR↓ Sell$4.0M
Feb 19, 2026UTHR↓ Sell$4.0M
Feb 5, 2026UTHR↓ Sell$4.0M
Jan 15, 2026UTHR↓ Sell$3.9M
Jan 2, 2026UTHR↓ Sell$4.0M
Dec 11, 2025UTHR↓ Sell$5.3M
Nov 26, 2025UTHR↓ Sell$5.3M
Nov 13, 2025UTHR↓ Sell$5.1M
Oct 30, 2025UTHR↓ Sell$5.0M
Oct 16, 2025UTHR↓ Sell$4.7M
Oct 2, 2025UTHR↓ Sell$4.8M
Sep 18, 2025UTHR↓ Sell$4.5M
Sep 4, 2025UTHR↓ Sell$4.2M
Aug 21, 2025UTHR↓ Sell$3.4M
Aug 7, 2025UTHR↓ Sell$3.3M
Jul 24, 2025UTHR↓ Sell$3.3M
Jul 10, 2025UTHR↓ Sell$3.3M
Jun 26, 2025UTHR↓ Sell$3.1M
Jun 12, 2025UTHR↓ Sell$3.1M
May 29, 2025UTHR↓ Sell$3.5M
May 15, 2025UTHR↓ Sell$3.2M
May 1, 2025UTHR↓ Sell$3.3M
Apr 17, 2025UTHR↓ Sell$3.1M
Apr 3, 2025UTHR↓ Sell$3.4M
Dec 5, 2024UTHR↓ Sell$2.9M
Nov 21, 2024UTHR↓ Sell$2.8M
Apr 4, 2024UTHR↓ Sell$1.4M
Mar 21, 2024UTHR↓ Sell$1.4M
Mar 7, 2024UTHR↓ Sell$1.4M
Feb 15, 2024UTHR↓ Sell$1.3M
Feb 1, 2024UTHR↓ Sell$1.3M
Jan 18, 2024UTHR↓ Sell$1.3M
Jan 4, 2024UTHR↓ Sell$1.4M
Dec 21, 2023UTHR↓ Sell$1.4M
Dec 7, 2023UTHR↓ Sell$1.4M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other UTHR insiders

Open-market trades in the last 12 months

About Paul A Mahon's insider trades

Paul A Mahon is EVP & General Counsel at UNITED THERAPEUTICS (UTHR). Since May 6, 2005, Paul has reported no open-market purchases and 307 sales worth $337.5M on SEC Form 4. In the last 12 months: 23 sales ($103.8M).

72 sales (10% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (429 filings), shares returned to the company (120 filings), grants and awards (20 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UTHR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.